There is current debate regarding the relative merits and roles of surgical revascularization and percutaneous revascularization for patients with obstructive coronary artery disease. This article reviews the current literature relating to this subject.
Get full access to this article
View all access options for this article.
References
1.
Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol2000; 35: 1122–9.
2.
KurbaanASBowkerTJIlsleyCDSigwartURickardsAF. On behalf of the CABRI Investigators (Coronary Angioplasty versus Bypass Revascularization Investigation). Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol2001; 87: 947–50.
3.
CareyJSDanielsenBGoldJPRossiterSJ. Procedure rates and outcomes of coronary revascularization procedures in California and New York. J Thorac Cardiovasc Surg2005; 129: 1276–82.
4.
FischmanDLLeonMBBaimDSSchatzRASavageMPPennI. Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med1994; 331: 496–501.
5.
SerruysPWde JaegerePKiemeneijFMacayaCRutschWHeyndrickxG. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med1994; 331: 489–95.
6.
SerruysPWvan HoutBBonnierHLegrandVGarciaEMacayaC. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet1998; 352: 673–81.
7.
StraussBHUmansVAvan SuylenRJde FeyterPJMarcoJRobertsonGC. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results. J Am Coll Cardiol1992; 20: 1465–73.
8.
BertrandMELablancheJMLeroyFBautersCDe JaegerePSerruysPW. Percutaneous transluminal coronary rotary ablation with Rotablator (European experience). Am J Cardiol1992; 69: 470–4.
9.
RamsdaleDRMorrisJL. If Rotablator is useful, why don't we use it?Heart1997; 78 Suppl 2:36–7.
10.
StoneGWde MarchenaEDagefordeDFoschiAMuhlesteinJBMcIvorM. Prospective, randomized, multicenter comparison of laser-facilitated balloon angioplasty versus stand-alone balloon angioplasty in patients with obstructive coronary artery disease. The Laser Angioplasty Versus Angioplasty (LAVA) Trial Investigators. J Am Coll Cardiol1997; 30: 1714–21.
11.
SerruysPWOngATvan HerwerdenLASousaJEJateneABonnierJJ. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol2005; 46: 575–81.
12.
RodriguezAEBaldiJPereiraC FernandezNaviaJAlemparteM RodriguezDelacasaA. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol2005; 46: 582–8.
13.
HuebWSoaresPRGershBJCesarLALuzPLPuigLB. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol2004; 43: 1743–51.
14.
SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomized controlled trial. Lancet2002; 360: 965–70.
15.
HoffmanSNTenBrookJAWolfMPPaukerSGSalemDNWongJB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol2003; 41: 1293–304.
16.
BrenerSJLytleBWCasserlyIPSchneiderJPTopolEJLauerMS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation2004; 109: 2290–5.
17.
MercadoNWijnsWSerruysPWSigwartUFlatherMDStablesRH. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg2005; 130: 512–9.
18.
HannanELRaczMJWalfordGJonesRHRyanTJBennettE. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med2005; 352: 2174–83.
19.
MackMJBrownPPKugelmassADBattagliaSLTarkingtonLGSimonAW. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg2004; 77: 761–8.
20.
van DomburgRTTakkenbergJJNoordzijLJSaiaFvan HerwerdenLASerruysPW. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study. Ann Thorac Surg2005; 79: 1563–9.
21.
MorrisonDASethiGSacksJHendersonWGroverFSedlisS. Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: the VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol2002; 39: 266–73.
22.
GoyJJKaufmannUGoy-EggenbergerDGarachemaniAHurniMCarrelT. A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc2000; 75: 1116–23.
23.
MoriceMCSerruysPWSousaJEFajadetJHayashiE BanPerinM. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med2002; 346: 1773–80.
24.
MosesJWLeonMBPopmaJJFitzgeraldPJHolmesDRO'ShaughnessyC. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med2003; 349: 1315–23.
25.
SchampaertECohenEASchluterMReevesFTraboulsiMTitleLM. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol2004; 43: 1110–5.
26.
SchoferJSchluterMGershlickAHWijnsWGarciaESchampaertE. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet2003; 362: 1093–9.
27.
ArdissinoDCavalliniCBramucciEIndolfiCMarzocchiAManariA. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA2004; 292: 2727–34.
28.
KelbaekHThuesenLHelqvistSKlovgaardLJorgensenEAljabbariS. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial. J Am Coll Cardiol2006; 47: 449–55.
29.
StoneGWEllisSGCoxDAHermillerJO'ShaughnessyCMannJT. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation2004; 109: 1942–7.
30.
StoneGWEllisSGCannonLMannJTGreenbergJDSpriggsD. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA2005; 294: 1215–23.
31.
DawkinsKDGrubeEGuagliumiGBanningAPZmudkaKColomboA. TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation2005; 112: 3306–13.
RegarELemosPASaiaFDegertekinMTanabeKLeeCH. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol2004; 93: 1271–5.
34.
McFaddenEPStabileERegarECheneauEOngATKinnairdT. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet2004; 364: 1519–21.
35.
OrtolaniPArdissinoDCavalliniCBramucciEIndolfiCAquilinaM. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy). Am J Cardiol2005; 96: 1393–8.
36.
KappeteinAPDawkinsKDMohrFWMoriceMCMackMJRussellME. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg2006; 29: 486–91.
37.
SerruysPWLemosPAvan HoutBA; Arterial Revascularisation Therapies Study part II Steering Committee and Investigators. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II). Heart2004; 90: 995–8.
38.
FlahertyJDDavidsonCJ. Diabetes and coronary revascularization. JAMA2005; 293: 1501–8.
39.
MalenkaDJLeavittBJHearneMJRobbJFBaribeauYRRyanTJ. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation2005; 112 (9 Suppl): I371–6.
40.
WhiteHDAssmannSFSanbornTAJacobsAKWebbJGSleeperLA. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation2005; 112: 1992–2001.
41.
TaggartDP. Surgery is the best intervention for severe coronary artery disease. BMJ2005; 330: 785–6.
42.
GershBJFryeRL. Methods of coronary revascularization—things may not be as they seem. New Engl J Med2005; 352: 2235–7.
43.
LeeCN. Do drug-eluting stents mark the end of coronary artery bypass surgery?Asian Cardiovasc Thorac Ann2005; 13: 1–3.
44.
KleinLW. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?J Am Coll Cardiol2006; 47: 22–6.
45.
BavryAAKumbhaniDJHeltonTJBorekPPMoodGRBhattDL. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med2006; 119: 1056–61.
46.
PfistererMBrunner-La RoccaHPBuserPTRickenbacherPHunzikerPMuellerC. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol2006; 48: 2584–91.
47.
GrinesCLBonowROCaseyDEJrGardnerTJLockhartPBMoliternoDJ. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation2007 Jan 15;[Epub ahead of print]
